377 Uroverse for robotic partial nephrectomy Dr Francesco Porpiglia

3 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
This video is being presented at the Humans at the Cutting Edge of Robotic Surgery Symposium 2024, Jaipur, India. It was produced by Dr Francesco Porpiglia, Division of Urology, Department of Oncology, School of Medicine University of Turin - San Luigi Gonzaga Hospital and IRCCS Candiolo Cancer Institute, Turin, Italy.
Abstract:
Uroverse for robotic partial nephrectomy
Enrico Checcucci, Gabriele Volpi, Federico Piramide, Daniele Amaprore, Sabrina De Cillis, Paolo
Alessio, Michele Sica, Cristian Fiori, Francesco Porpiglia
Surgeon: Prof. Francesco Porpiglia
Introduction & objectives: The Metaverse is an immersive environment combining virtual and
physical entities. A pioneering study investigated the use of 3D models for surgical planning in
partial nephrectomy (PN) within the Metaverse. In our research, we introduce for the first time
the use of "Uroverse" navigation during robot-assisted PN (RAPN), enabled by advancements in 3D
modeling and Metaverse technology.
Materials & Methods: During the 12th Techno Urology Meeting, the Metaverse experience was
improved in three main aspects and dubbed "Uroverse." 3D models attained unprecedented
fidelity, becoming "digital twins" of real organs. The immersive nature of the Metaverse was
heightened with avatars replicating users' appearances and an environment mimicking a surgical
theater. Preoperative navigation was ameliorated, with new headsets improving the interaction
with the models. Additionally, the Uroverse experience was integrated into the robotic console,
facilitating an intraoperative consultation of the model. This technology enabled surgeons and
moderators to virtually meet in the same room, despite being physically apart.
Results: Seven patients underwent RAPN with Metaverse surgical planning. Based on digital twin
models, the clamping strategy was global in 4 (57.2%) and selective in 3 patients (42.8%).
Enucleation and enucleoresection were performed in 3 (42.8%) and 4 (57.2%) patients,
respectively. Selective management of intraparenchymal structures was carried out in 4 cases.
Median warm ischemia time was 12 minutes (IQR 10–16.5). No intraoperative complications were
recorded; 3 postoperative complications were noted.
Conclusions: The Uroverse experience allows a “tailored” surgical planning and acts as a valuable
tool for surgeons’ assistance during the intervention.

See more at: http://vattikutifoundation.com/
Category
Urology
Be the first to comment

Up Next